Brevan Howard Capital Management’s Pacira BioSciences PCRX Stock Holding History

Brevan Howard Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$431K	Buy
2025 Q3	$306K	Sell
2025 Q2	$660K	Buy
2025 Q1	$201K	Sell
2024 Q4	$637K	Buy
2024 Q2	–	Sell
2024 Q1	$216K	Sell
2023 Q4	$507K	Buy